Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 174

1.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.

Xu W, Wang HF, Tan L, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative Group.

Sci Rep. 2016 Apr 27;6:24480. doi: 10.1038/srep24480.

2.

Psychiatric Aspects of Dementia.

Onyike CU.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):600-14. doi: 10.1212/CON.0000000000000302.

PMID:
27042910
3.

In vivo imaging of neurodegeneration in dementia with Lewy bodies (DLB).

Onyike CU, Smith GS.

Int Psychogeriatr. 2016 Apr;28(4):527-8. doi: 10.1017/S1041610216000156.

PMID:
27009322
4.

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, Maki PM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Mar 16. pii: 10.1212/WNL.0000000000002570. [Epub ahead of print]

PMID:
26984945
5.

Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis.

Kansal K, Mareddy M, Sloane KL, Minc AA, Rabins PV, McGready JB, Onyike CU.

Dement Geriatr Cogn Disord. 2016;41(1-2):109-22. doi: 10.1159/000443205. Epub 2016 Feb 9.

6.

Emerging therapies in Friedreich's ataxia.

Aranca TV, Jones TM, Shaw JD, Staffetti JS, Ashizawa T, Kuo SH, Fogel BL, Wilmot GR, Perlman SL, Onyike CU, Ying SH, Zesiewicz TA.

Neurodegener Dis Manag. 2016 Feb;6(1):49-65. doi: 10.2217/nmt.15.73.

PMID:
26782317
7.

Periventricular hyperintensities are associated with elevated cerebral amyloid.

Marnane M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, Wang BW, Feldman HH, Hsiung GY; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Feb 9;86(6):535-43. doi: 10.1212/WNL.0000000000002352. Epub 2016 Jan 8.

PMID:
26747881
8.

Highly adaptive tests for group differences in brain functional connectivity.

Kim J, Pan W; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2015 Oct 22;9:625-39. doi: 10.1016/j.nicl.2015.10.004. eCollection 2015.

9.

MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.

Hua X, Ching CR, Mezher A, Gutman BA, Hibar DP, Bhatt P, Leow AD, Jack CR Jr, Bernstein MA, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2016 Jan;37:26-37. doi: 10.1016/j.neurobiolaging.2015.09.018. Epub 2015 Oct 19.

10.

A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.

Deming Y, Xia J, Cai Y, Lord J, Holmans P, Bertelsen S, Holtzman D, Morris JC, Bales K, Pickering EH, Kauwe J, Goate A, Cruchaga C; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2016 Jan;37:208.e1-9. doi: 10.1016/j.neurobiolaging.2015.09.009. Epub 2015 Sep 25.

PMID:
26545630
11.

Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment.

David ND, Lin F, Porsteinsson AP; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2016 Jan;24(1):70-80. doi: 10.1016/j.jagp.2015.06.001. Epub 2015 Jun 27.

PMID:
26525995
12.

Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt-Jakob disease, and Alzheimer's disease.

Uflacker A, Edmondson MC, Onyike CU, Appleby BS.

Int Psychogeriatr. 2016 Feb;28(2):269-73. doi: 10.1017/S1041610215001647. Epub 2015 Oct 5.

PMID:
26435062
13.

Suspected non-AD pathology in mild cognitive impairment.

Wisse LE, Butala N, Das SR, Davatzikos C, Dickerson BC, Vaishnavi SN, Yushkevich PA, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Dec;36(12):3152-62. doi: 10.1016/j.neurobiolaging.2015.08.029. Epub 2015 Sep 7.

PMID:
26422359
14.

Study of amyloid-β peptide functional brain networks in AD, MCI and HC.

Jiang J, Duan H, Huang Z, Yu Z; Alzheimer's Disease Neuroimaging Initiative.

Biomed Mater Eng. 2015;26 Suppl 1:S2197-205. doi: 10.3233/BME-151525.

PMID:
26405999
15.

Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.

Wang C, Tan L, Wang HF, Yu WJ, Liu Y, Jiang T, Tan MS, Hao XK, Zhang DQ, Yu JT; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;46(2):491-5. doi: 10.3233/JAD-150110.

PMID:
26402410
16.

Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.

Zhan Y, Chen K, Wu X, Zhang D, Zhang J, Yao L, Guo X; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):1057-67. doi: 10.3233/JAD-142820.

PMID:
26401783
17.

Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.

Malpas CB, Saling MM, Velakoulis D, Desmond P, O'Brien TJ; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):965-75. doi: 10.3233/JAD-142643.

PMID:
26401775
18.

Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study.

Klöppel S, Peter J, Ludl A, Pilatus A, Maier S, Mader I, Heimbach B, Frings L, Egger K, Dukart J, Schroeter ML, Perneczky R, Häussermann P, Vach W, Urbach H, Teipel S, Hüll M, Abdulkadir A; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):939-54. doi: 10.3233/JAD-150334.

PMID:
26401773
19.

Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis.

Michaud TL, Kane RL, McCarten JR, Gaugler JE, Nyman JA, Kuntz KM; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(3):729-40. doi: 10.3233/JAD-150066.

PMID:
26401707
20.

Comment: Toward a physiology of eating disorder in frontotemporal dementia.

Onyike CU.

Neurology. 2015 Oct 13;85(15):1316. doi: 10.1212/WNL.0000000000002027. Epub 2015 Sep 16. No abstract available.

PMID:
26377251
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk